Last reviewed · How we verify
Mucocutaneous candidiasis
Approved treatments
- Mycostatin · Generic (originally Squibb)
- Diflucan · Pfizer Inc.
- Fluconazol · Azienda Sanitaria-Universitaria Integrata di Udine
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Mucocutaneous candidiasis patent landscape — cliff calendar, originator estates, attackable patents
- Mucocutaneous candidiasis treatment landscape brief
- Mucocutaneous candidiasis treatment updates RSS
Frequently asked questions about Mucocutaneous candidiasis
What drugs treat Mucocutaneous candidiasis?
Tracked treatments include Mycostatin, Diflucan, Fluconazol.
What is the treatment for Mucocutaneous candidiasis?
Standard treatment for Mucocutaneous candidiasis includes Mycostatin, Diflucan, Fluconazol. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Mucocutaneous candidiasis patent cliff · Mucocutaneous candidiasis CI report
- Treatment: Mycostatin · Generic (originally Squibb)
- Treatment: Diflucan · Pfizer Inc.
- Treatment: Fluconazol · Azienda Sanitaria-Universitaria Integrata di Udine
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing